A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adults
Open Access
- 5 July 2004
- journal article
- clinical trial
- Published by Wiley in HIV Medicine
- Vol. 5 (4) , 296-302
- https://doi.org/10.1111/j.1468-1293.2004.00224.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samplesAIDS, 2003
- Treatment with Lopinavir/Ritonavir in Heavily Pretreated Subjects Failing Multiple Antiretroviral Regimens in Clinical PracticeJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Improved Viral Fitness In VitroJournal of Virology, 2002
- Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influence of Viral Susceptibility to Coadministered Reverse Transcriptase Nucleoside InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse‐Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1–Infected Protease Inhibitor–Experienced PatientsThe Journal of Infectious Diseases, 2002
- Low Frequency of Severe Hepatotoxicity and Association With HCV Coinfection in HIV-Positive Patients Treated With HAARTJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Pharmacokinetic and Pharmacodynamic Study of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir after Multiple Oral DosingAntimicrobial Agents and Chemotherapy, 2001
- Low Level of Cross-Resistance to Amprenavir (141W94) in Samples from Patients Pretreated with Other Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2000
- Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapiesAIDS, 1999
- Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavirAIDS, 1999